Appreciate the recommendation. Having not read the book, would it make sense to reach out to the author to make him aware that Cytodyn is starting out with great success (https://www.charlesgraeber.com/contact)?

It seems that what we are lacking is other people knowing that we exist. It is just mind boggling. I know we are new to the cancer space but having so many years of use in other indications with no SAEs should put us to the top of the lists for people to consider IMO.

I sent messages to a few of the cancer related groups just to give them a heads up. It's such a delicate topic, but everything I've read makes me so optimistic that this could help many people in such dire straits that I want them to know about it at least.

For the MDs out there, how do oncologists learn about treatments like this? It will be awhile before we see leronlimab infomercials...how can we help get this on the radar of the right people?